Jpmorgan Chase & CO Guardant Health, Inc. Transaction History

Jpmorgan Chase & CO

  • $1.27 Trillion
  • Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Guardant Health, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 176,223 shares of GH stock, worth $8.07 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
176,223
Previous 677,126 73.97%
Holding current value
$8.07 Million
Previous $20.7 Million 63.71%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 12, 2025
SELL
$31.77 - $49.94 $15.9 Million - $25 Million
-500,903 Reduced 73.97%
176,223 $7.51 Million
Q4 2024

Feb 12, 2025
BUY
$20.2 - $38.11 $9.65 Million - $18.2 Million
477,582 Added 239.34%
677,126 $20.7 Million
Q3 2024

Dec 26, 2024
SELL
$22.3 - $36.29 $5.13 Million - $8.34 Million
-229,841 Reduced 53.53%
199,544 $4.58 Million
Q3 2024

Nov 08, 2024
SELL
$22.3 - $36.29 $5.13 Million - $8.34 Million
-229,841 Reduced 53.53%
199,544 $4.58 Million
Q2 2024

Dec 26, 2024
BUY
$16.07 - $31.84 $3.69 Million - $7.32 Million
229,841 Added 115.18%
429,385 $12.4 Million
Q2 2024

Aug 12, 2024
BUY
$16.07 - $31.84 $4.32 Million - $8.57 Million
269,134 Added 167.95%
429,385 $12.4 Million
Q1 2024

Dec 26, 2024
SELL
$17.13 - $26.91 $673,089 - $1.06 Million
-39,293 Reduced 19.69%
160,251 $3.31 Million
Q1 2024

May 10, 2024
SELL
$17.13 - $26.91 $5.53 Million - $8.68 Million
-322,562 Reduced 66.81%
160,251 $3.31 Million
Q4 2023

Dec 26, 2024
BUY
$21.58 - $29.5 $6.11 Million - $8.36 Million
283,269 Added 141.96%
482,813 $13.1 Million
Q4 2023

Feb 12, 2024
BUY
$21.58 - $29.5 $1.28 Million - $1.74 Million
59,090 Added 13.95%
482,813 $13.1 Million
Q3 2023

Nov 14, 2023
SELL
$25.8 - $39.97 $6.82 Million - $10.6 Million
-264,227 Reduced 38.41%
423,723 $12.6 Million
Q2 2023

Aug 11, 2023
BUY
$20.94 - $38.01 $939,221 - $1.7 Million
44,853 Added 6.97%
687,950 $24.6 Million
Q1 2023

May 18, 2023
BUY
$22.92 - $33.76 $1.31 Million - $1.93 Million
57,266 Added 9.78%
643,097 $15.1 Million
Q1 2023

May 11, 2023
BUY
$22.92 - $33.76 $9.19 Million - $13.5 Million
400,775 Added 216.57%
585,831 $13.7 Million
Q4 2022

Feb 13, 2023
SELL
$25.44 - $59.78 $20.7 Million - $48.6 Million
-812,649 Reduced 81.45%
185,056 $5.03 Million
Q3 2022

Nov 14, 2022
BUY
$43.66 - $61.0 $35.9 Million - $50.2 Million
822,954 Added 470.93%
997,705 $53.7 Million
Q2 2022

Aug 11, 2022
SELL
$28.82 - $77.35 $441,320 - $1.18 Million
-15,313 Reduced 8.06%
174,751 $7.05 Million
Q1 2022

May 11, 2022
SELL
$48.25 - $100.49 $2.49 Million - $5.19 Million
-51,601 Reduced 21.35%
190,064 $12.6 Million
Q4 2021

Feb 10, 2022
BUY
$88.71 - $120.43 $11.1 Million - $15.1 Million
125,082 Added 107.29%
241,665 $24.2 Million
Q3 2021

Nov 12, 2021
BUY
$98.77 - $132.17 $11.5 Million - $15.4 Million
116,583 New
116,583 $14.6 Million

Others Institutions Holding GH

# of Institutions
393
Shares Held
121M
Call Options Held
1.43M
Put Options Held
2.37M
View Full List

About Guardant Health, Inc.

GH Quotes by TradingView
  • Ticker GH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 102,220,000
  • Market Cap $4.68B
  • Description
  • Guardant Health, Inc., a precision oncology company, provides blood tests, data sets, and analytics in the United States and internationally. The company offers Guardant360, Guardant360 LDT, Guardant360 CDx, and GuardantOMNI liquid biopsy-based tests for advanced stage cancer; and GuardantINFORM, an in-silico research platform that comprise a cl...
More about GH
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email